Sosei Heptares and Aditum Bio create new company - Tempero Bio - to advance the clinical development of mGlu5 NAM program in neurological diseases ...Middle East

PR Newswire - News
Sosei Heptares and Aditum Bio create new company - Tempero Bio - to advance the clinical development of mGlu5 NAM program in neurological diseases
TOKYO and CAMBRIDGE, England, Nov. 2, 2020 /PRNewswire/ -- Sosei Group Corporation ("the Company") (TSE: 4565) has entered into an agreement1 with Tempero Bio, under which Tempero Bio has in-licensed exclusive global rights to Sosei Heptares' mGlu5 negative allosteric modulator (NAM)...

Hence then, the article about sosei heptares and aditum bio create new company tempero bio to advance the clinical development of mglu5 nam program in neurological diseases was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Sosei Heptares and Aditum Bio create new company - Tempero Bio - to advance the clinical development of mGlu5 NAM program in neurological diseases )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News